| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 111 | 15 | 4 | 28 | | Cost of Revenue | 172 | 43 | 6 | 4 | | | Gross Profit | (61) | (28) | (1) | 24 | | | Operating Expenses | | Research Development | 2,191 | 5,828 | 3,535 | 3,003 | | Selling General and Administrative | 2,807 | 1,052 | 1,805 | 2,129 | | Non Recurring |
-
| (87) |
-
| 87 | | Others | 424 | 367 | 334 | 313 | | | | Total Operating Expenses |
-
| 7,160 |
-
| 5,532 | | | | Operating Income or Loss | (5,483) | (7,188) | (5,675) | (5,508) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 31 | 55 | 76 | | Earnings Before Interest And Taxes | (5,473) | (7,157) | (5,621) | (5,432) | | Interest Expense | 67 | 71 |
-
|
-
| | Income Before Tax | (5,540) | (7,228) | (5,621) | (5,432) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,540) | (7,228) | (5,621) | (5,432) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,540) | (7,228) | (5,621) | (5,432) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,540) | ($7,228) | ($5,621) | ($5,432) |
|
3.07% Nasdaq 
0.006 (0.91%) 
Income Statement
